BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8808718)

  • 1. Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study.
    Pisani E; Bartoletti R; Trinchieri A; Rizzo M
    J Chemother; 1996 Jun; 8(3):210-3. PubMed ID: 8808718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
    Cox CE
    Am J Med; 1992 Apr; 92(4A):82S-86S. PubMed ID: 1316077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncomplicated urinary tract infections: lomefloxacin versus trimethoprim/sulphamethoxazole.
    Guibert J; Capron MH
    J Int Med Res; 1992 Nov; 20(6):467-74. PubMed ID: 1337525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis.
    Naber KG;
    Int J Antimicrob Agents; 2002 Jul; 20(1):18-27. PubMed ID: 12127707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections.
    Carmignani G; De Rose AF; Olivieri L; Salvatori E; Rosignoli MT; Dionisio P
    Urol Int; 2005; 74(4):326-31. PubMed ID: 15897698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
    Naber KG; Allin DM; Clarysse L; Haworth DA; James IG; Raini C; Schneider H; Wall A; Weitz P; Hopkins G; Ankel-Fuchs D
    Int J Antimicrob Agents; 2004 Jun; 23(6):596-605. PubMed ID: 15194131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the safety and efficacy of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infections: results from a multicenter study.
    Andrade-Villanueva J; Flores-Gaxiola A; Lopez-Guillen P; Aguirre-Avalos G; Morfin-Otero R; Rodriguez-Noriega E
    Am J Med; 1992 Apr; 92(4A):71S-74S. PubMed ID: 1316074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.
    Neringer R; Forsgren A; Hansson C; Ode B
    Scand J Infect Dis; 1992; 24(6):773-80. PubMed ID: 1337623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
    Savitskaia KI; Trapeznikova MF; Nekhorosheva AG; Solodilova OE; Nasonov VN; Dutov VV; Kalinin VN; Shanina AG; Rusanova EV
    Klin Med (Mosk); 1994; 72(2):38-42. PubMed ID: 8015241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women.
    Stein GE; Philip E
    J Fam Pract; 1992 Feb; 34(2):180-4. PubMed ID: 1310715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.
    Henry DC; Nenad RC; Iravani A; Tice AD; Mansfield DL; Magner DJ; Dorr MB; Talbot GH
    Clin Ther; 1999 Jun; 21(6):966-81. PubMed ID: 10440621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults.
    Iravani A
    Am J Med; 1992 Apr; 92(4A):75S-81S. PubMed ID: 1316075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
    Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
    J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection.
    Klimberg IW; Cox CE; Fowler CL; King W; Kim SS; Callery-D'Amico S
    Urology; 1998 Apr; 51(4):610-5. PubMed ID: 9586615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone.
    Rizk E
    Am J Med; 1992 Apr; 92(4A):130S-135S. PubMed ID: 1316063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections.
    Hoepelman IM; Havinga WH; Benne RA; Zwinkels M; de Wit MA; de Hond HA; Boon TA; Visser MR; van Asbeck FW; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):343-7. PubMed ID: 8394815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis.
    Cox CE; Marbury TC; Pittman WG; Brown GL; Auerbach SM; Fox BC; Yang JY
    Clin Ther; 2002 Feb; 24(2):223-36. PubMed ID: 11911553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
    Grassi C; Salvatori E; Rosignoli MT; Dionisio P;
    Respiration; 2002; 69(3):217-22. PubMed ID: 12097764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers.
    Booranapong W; Kosrirukvongs P; Prabhasawat P; Srivannaboon S; Suttiprakarn P
    J Med Assoc Thai; 2004 Mar; 87(3):246-54. PubMed ID: 15117040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.